{"schema_version":"secwatch.filing_event.v1","accession":"0001601830-23-000075","form_type":"8-K","ticker":"RXRX","cik":"0001601830","company_name":"RECURSION PHARMACEUTICALS, INC.","filed_at":"2023-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.723998+00:00","generated_at":"2026-06-07T11:56:11.370863+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Recursion registers 3.2M shares of Class A common stock for resale by Tempus Labs","bullets":["3,225,902 shares registered for resale by Tempus Labs as payment for initial license fee under Master Agreement.","Prospectus supplement filed under effective shelf registration statement (Form S-3ASR) on December 15, 2023.","Shares were originally issued to Tempus in November 2023 per the Master Agreement described in prior Form 8-K.","Resale offering is exempt from registration under the Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001601830-23-000075","json":"https://secwatch.observer/filing/0001601830-23-000075.json","markdown":"https://secwatch.observer/filing/0001601830-23-000075.md","text":"https://secwatch.observer/filing/0001601830-23-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/0001601830-23-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/rxrx-20231215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:56:11.370863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}